BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25195779)

  • 1. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.
    Ishiguro C; Wang X; Li L; Jick S
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1168-75. PubMed ID: 25195779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study.
    Wu CS; Lin CC; Chang CM; Wu KY; Liang HY; Huang YW; Tsai HJ
    J Clin Psychiatry; 2013 Sep; 74(9):918-24. PubMed ID: 24107765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia.
    Schmedt N; Garbe E
    J Clin Psychopharmacol; 2013 Dec; 33(6):753-8. PubMed ID: 24052055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antipsychotics and risk of venous thromboembolism in postmenopausal women. A population-based nested case-control study.
    Wang MT; Liou JT; Huang YW; Lin CW; Wu GJ; Chu CL; Yeh CB; Wang YH
    Thromb Haemost; 2016 Jun; 115(6):1209-19. PubMed ID: 26941052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study.
    Parker C; Coupland C; Hippisley-Cox J
    BMJ; 2010 Sep; 341():c4245. PubMed ID: 20858909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
    Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
    JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotics and venous thromboembolism risk: a meta-analysis.
    Zhang R; Dong L; Shao F; Tan X; Ying K
    Pharmacopsychiatry; 2011 Jul; 44(5):183-8. PubMed ID: 21739416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
    Jick H; Derby LE; Myers MW; Vasilakis C; Newton KM
    Lancet; 1996 Oct; 348(9033):981-3. PubMed ID: 8855853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study.
    Zornberg GL; Jick H
    Lancet; 2000 Oct; 356(9237):1219-23. PubMed ID: 11072939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory drugs and venous thromboembolism in women.
    Bergendal A; Adami J; Bahmanyar S; Hedenmalm K; Lärfars G; Persson I; Sundström A; Kieler H
    Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):658-66. PubMed ID: 23508885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study.
    Lacut K; Le Gal G; Couturaud F; Cornily G; Leroyer C; Mottier D; Oger E
    Fundam Clin Pharmacol; 2007 Dec; 21(6):643-50. PubMed ID: 18034665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic drugs and fatal pulmonary embolism.
    Parkin L; Skegg DC; Herbison GP; Paul C
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):647-52. PubMed ID: 14762980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thromboembolism in users of hormone replacement therapy.
    Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
    Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant drug use and risk of venous thromboembolism.
    Jick SS; Li L
    Pharmacotherapy; 2008 Feb; 28(2):144-50. PubMed ID: 18225961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study.
    Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP
    Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic Drugs and Risk of Developing Venous Thromboembolism and Pulmonary Embolism: A Systematic Review and Meta-Analysis.
    Arasteh O; Nomani H; Baharara H; Sadjadi SA; Mohammadpour AH; Ghavami V; Sathyapalan T; Sahebkar A
    Curr Vasc Pharmacol; 2020; 18(6):632-643. PubMed ID: 32066363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
    Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
    Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
    Sundström A; Seaman H; Kieler H; Alfredsson L
    BJOG; 2009 Jan; 116(1):91-7. PubMed ID: 19016686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.